Pular para o conteúdo

Interações medicamentosas

Cobimetinib + Netupitant-palonosetron

Gravidade: Grave

Cobimetinib and Netupitant-palonosetron: major interaction.

Última atualização

Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.

O conteúdo clínico desta página está disponível apenas em inglês.

Resumo

Netupitant inhibits CYP3A4 and can increase cobimetinib exposure. This may increase toxicities such as hemorrhage, rhabdomyolysis, retinopathy and liver injury.

O que esta interação significa em palavras simples

Cobimetinib and Netupitant-palonosetron can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Cobimetinib belongs to Oncology; Netupitant-palonosetron belongs to Gastrointestinal Tract.

Nível de evidência: Moderate

Por que acontece

CYP3A4 inhibition by netupitant reduces cobimetinib clearance.

O que fazer

Prefer an antiemetic that does not inhibit CYP3A4. If short-term use is unavoidable, reduce cobimetinib to the labeled dose for moderate inhibitors and monitor for toxicity.

O que perguntar ao farmacêutico

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Para assinantes do Pro+

Desbloqueie a página completa

Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Cobimetinib e Netupitant-palonosetron, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Experimente o Pro+ grátis por 14 dias na web. Sem cartão.

Perguntas frequentes

Can I take Cobimetinib with Netupitant-palonosetron?

MediHelp rates the interaction as major. Cobimetinib and Netupitant-palonosetron can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Netupitant inhibits CYP3A4 and can increase cobimetinib exposure. This may increase toxicities such as hemorrhage, rhabdomyolysis, retinopathy and liver injury.

How serious is the interaction between Cobimetinib and Netupitant-palonosetron?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer an antiemetic that does not inhibit CYP3A4. If short-term use is unavoidable, reduce cobimetinib to the labeled dose for moderate inhibitors and monitor for toxicity.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Monografias completas, posologia e verificador de interações no app MediHelp

Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.

Explorar de A a Z · Interações medicamentosas

Baixar o app Entrar